Article

Understanding the Measles Virus at 70 Years: From Cellular Mechanisms to Immunisation, 1954-2024

2024-07-16

Abstract excerpt

Measles virus (_Morbillivirus_ abbreviated as MV, but more recently MeV) is the causal agent of Measles disease, thought to have existed at least 4000 years ago, affecting predominantly infants, but also immunocompromised individuals and others remaining a public health issue today globally. In this review, we are discussing the historical background about MeV infection to modern–day research, then delving into Me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d32e0dde-b0f9-5e44-88a9-1cd6c312dc3e
DOI: 10.32388/nggcj9.4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Understanding the Measles Virus at 70 Years: From Cellular Mechanisms to Immunisation, 1954-2024DOI 10.32388/nggcj9.4Read

Measles Virus-Induced Host Immunity and Mechanisms of Viral EvasionSemantic proximity Read

Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the BrainSemantic proximity Read

Clinico-virological investigation of measles complications in immunocompromised pediatric patients.Semantic proximity Read

Molecular biology, pathogenesis and pathology of mumps virus.Semantic proximity Read

Pathological consequences of systemic measles virus infection.Semantic proximity Read

Measles virus nomenclature update: 2012.Semantic proximity Read

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccinesSemantic proximity Read

Measles virus: Background and oncolytic virotherapySemantic proximity Read

High rates of hepatic involvement associated with new epidemic measles strains in Romania.Semantic proximity Read

[Measles].Semantic proximity Read

Measles Virus Fusion Protein: Structure, Function and InhibitionSemantic proximity Read

A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 VaccineSemantic proximity Read